Golden Toxicology LLC

Golden Toxicology LLC was paid $1.13M by Medicaid between Jan 2018 and Dec 2022, across 23 billing codes. Its largest line is G0481, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed — 27% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Oregon

Rank by total paid#17 of 46

Median peer was paid$50K

This provider vs. median23×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	10,105	$571K
2019	3,408	$266K
2020	2,018	$167K
2021	1,001	$72K
2022	842	$52K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	27%	3,258	3,229	$307K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	21%	3,698	3,651	$233K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	19%	1,260	1,244	$218K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	9.3%	1,705	1,703	$105K
80361		1.7%	435	428	$20K
80362		1.7%	435	428	$20K
80346		1.6%	435	428	$19K
80357		1.6%	434	427	$18K
80369		1.6%	435	428	$18K
80358		1.5%	435	428	$16K
80324		1.4%	435	428	$16K
80353		1.4%	435	428	$15K

11 more codes

80359		1.3%	435	$14K
80372		1.3%	435	$14K
80348		1.3%	435	$14K
80365		1.3%	435	$14K
80354		1.3%	434	$14K
80335		1.2%	421	$14K
80373		1.2%	435	$14K
80345		1.0%	434	$12K
80349		<1%	159	$5K
80350		<1%	159	$5K
83992		<1%	192	$3K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNOLES, DODIE (OPERATIONS MANAGER)

Same official

Other billing entities under NOLES, DODIE

Full network →

Provider	Location	Paid
Kolpia Counseling Service	Ashland, OR	$582K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.